These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35138206)

  • 1. A competing risks regression model for the association between time-varying opioid exposure and risk of overdose.
    Li X; Chang CH; Donohue JM; Krafty RT
    Stat Methods Med Res; 2022 Jun; 31(6):1013-1030. PubMed ID: 35138206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penalized variable selection in competing risks regression.
    Fu Z; Parikh CR; Zhou B
    Lifetime Data Anal; 2017 Jul; 23(3):353-376. PubMed ID: 27016934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
    Zhang X; Zhang MJ; Fine J
    Stat Med; 2011 Jul; 30(16):1933-51. PubMed ID: 21557288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regularized Weighted Nonparametric Likelihood Approach for High-Dimension Sparse Subdistribution Hazards Model for Competing Risk Data.
    Tapak L; Kosorok MR; Sadeghifar M; Hamidi O; Afshar S; Doosti H
    Comput Math Methods Med; 2021; 2021():5169052. PubMed ID: 34589136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive subdistribution hazards regression for competing risks data in case-cohort studies.
    Wogu AF; Li H; Zhao S; Nichols HB; Cai J
    Biometrics; 2023 Dec; 79(4):3010-3022. PubMed ID: 36606409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible parametric modelling of the cause-specific cumulative incidence function.
    Lambert PC; Wilkes SR; Crowther MJ
    Stat Med; 2017 Apr; 36(9):1429-1446. PubMed ID: 28008649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Opioid Overdose After an Initial Opioid Prescription.
    Weiner SG; El Ibrahimi S; Hendricks MA; Hallvik SE; Hildebran C; Fischer MA; Weiss RD; Boyer EW; Kreiner PW; Wright DA; Flores DP; Ritter GA
    JAMA Netw Open; 2022 Jan; 5(1):e2145691. PubMed ID: 35089351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries.
    Hernandez I; He M; Brooks MM; Zhang Y
    JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
    Bakoyannis G; Yu M; Yiannoutsos CT
    Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient estimation for left-truncated competing risks regression for case-cohort studies.
    Fang X; Ahn KW; Cai J; Kim S
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38281769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal semiparametric transformation models for clustered multivariate competing risks data.
    He Y; Kim S; Mao L; Ahn KW
    Stat Med; 2022 Nov; 41(26):5349-5364. PubMed ID: 36117139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible competing risks regression modeling and goodness-of-fit.
    Scheike TH; Zhang MJ
    Lifetime Data Anal; 2008 Dec; 14(4):464-83. PubMed ID: 18752067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
    JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.